Use of prostaglandin e2 (pge2)-primed mesenchymal stem cell (msc) product in preparation of drug for treating lung injury (li)
US-2023414667-A1 · Dec 28, 2023 · US
This page is not indexed by search engines while we improve data quality.
Univ Nankai patents in 2023
Univ Nankai was listed as an assignee on 23 patent publications in 2023.
| Metric | Value |
|---|---|
| Company | Univ Nankai |
| Year | 2023 |
| Patents | 23 |
Patents
Representative publications for Univ Nankai in 2023.
Method for preparing pyridine compound substituted with trifluoromethylthio, difluoromethylthio or trifluoromethyl in meta position
US-11851408-B2 · Dec 26, 2023 · US
Preparation method and application of decellularized extracellular matrix tissue paper
US-2023405186-A1 · Dec 21, 2023 · US
Application of sesquiterpene lactone compound in preparation of drugs for alleviating radiotherapy-induced injuries
US-2023398092-A1 · Dec 14, 2023 · US
Lithium niobate having p-type nanowire region or n-type nanowire region, method for preparing the same, and method for converting charge carrier type of nanowire region
US-11834755-B2 · Dec 5, 2023 · US
Top CPC classifications
Most common classification codes for Univ Nankai in 2023.
| CPC | Patents |
|---|---|
| C09K2208/22 | 3 |
| C09K8/42 | 3 |
| C09K8/80 | 3 |
| E21B43/01 | 3 |
| E21B43/16 | 3 |
Related pages
Navigate to parent entity pages.